Don’t edit the human germ line

Edward Lanphier (), Fyodor Urnov, Sarah Ehlen Haecker, Michael Werner and Joanna Smolenski
Additional contact information
Edward Lanphier: Edward Lanphier is president and chief executive officer of Sangamo BioSciences in Richmond, California, USA, and chairman of the Alliance for Regenerative Medicine in Washington DC, USA.
Fyodor Urnov: Fyodor Urnov is senior scientist at Sangamo BioSciences in Richmond, California, USA.
Sarah Ehlen Haecker: Sarah Ehlen Haecker is director of technology sections at the Alliance for Regenerative Medicine in Washington DC, USA.
Michael Werner: Michael Werner is executive director of the Alliance for Regenerative Medicine in Washington DC, USA.
Joanna Smolenski: Joanna Smolenski is a PhD student in philosophy at the Graduate Center of the City University of New York, New York, USA.

Nature, 2015, vol. 519, issue 7544, 410-411

Abstract: Heritable human genetic modifications pose serious risks, and the therapeutic benefits are tenuous, warn Edward Lanphier, Fyodor Urnov and colleagues.

Date: 2015
References: Add references at CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
https://www.nature.com/articles/519410a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:519:y:2015:i:7544:d:10.1038_519410a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/519410a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().